US stocks flat as Pfizer, Moderna shares tumble | Malay Mail
NEW YORK, May 6 — Wall Street stocks were little changed early today following upbeat US jobs data, while both Pfizer and Moderna slumped on worries about diminished profits from Covid-19 vaccines. US Labor Department said new applications for unemployment benefits fell to 498,000 last week, a...
Thursday, 06 May 2021 11:47 PM MYTPeople walk on Wall St. outside the New York Stock Exchange (NYSE) in New York August 7, 2019. — Reuters picSubscribe to ourTelegramchannel for the latest updates on news you need to know.NEW YORK, May 6 — Wall Street stocks were little changed early today following upbeat US jobs data, while both Pfizer and Moderna slumped on worries about diminished profits from Covid-19 vaccines.
US Labor Department said new applications for unemployment benefits fell to 498,000 last week, a new low since the pandemic began in March 2020.The figures come ahead of Friday’s highly-anticipated government jobs report for April, which is expected to show blowout employment gains.
About 20 minutes into trading, the Dow Jones Industrial Average was up 0.1 per cent at 34,256.18.The broad-based S&P 500 dipped 0.1 per cent to 4,163.75, while the tech-rich Nasdaq Composite Index dropped 0.3 per cent to 13,544.67.Markets have been choppy this week as investors have weighed improving economic data against worries over rising inflation and a potential shift in Federal Reserve monetary policy sooner than expected. headtopics.com
Pfizer fell 2.5 per cent and Moderna tumbled 8.5 per cent after the Biden administration backed a global waiver on patent protections for Covid-19 vaccines in an effort to get the doses out to poor countries more rapidly.The decision clouds the profit outlook for both companies after Pfizer said earlier this week it expected a “durable” revenue stream from Covid-19 vaccines and boosters.
Moderna on Thursday reported first-quarter profits of US$1.2 billion (RM4.9 billion), compared with a US$124 million loss in the year-ago period. — AFP Read more: Malay Mail »
Remand extended for cosmetics entrepreneur, friend in sexual grooming case
KAJANG: Police have extended the remand order on a cosmetics entrepreneur and his friend for alleged sexual grooming and obscene communication with minors.
US authorises Pfizer/BioNTech Covid vaccine for children 12 to 15 | Malay MailWASHINGTON, May 11 ― US regulators yesterday authorised Pfizer and BioNTech's Covid-19 vaccine for use in children as young as 12, widening the country's inoculation programme as vaccination rates have slowed significantly. The vaccine has been available under an emergency use authorisation (EUA)...
Pfizer asks UK regulator to approve vaccine for teenagers | Malay MailLONDON, May 12 — Pfizer Inc has submitted data on its Covid-19 vaccine among 12- to 15-year-olds to Britain’s health regulator, a company spokesman said on Tuesday, paving the way for its authorization to inoculate children in the country. “I can confirm we’ve submitted data on the efficacy...
Pfizer sees Covid-19 as 'durable' revenue stream as profits rise | Malay MailNEW YORK, May 5 ― Pfizer sharply increased its 2021 profit projections yesterday, citing much higher Covid-19 vaccine sales which are on track to provide a “durable” revenue stream in the wake of the pandemic. The drugmaker reported a jump in first-quarter profits based on surging revenues,...
Pfizer, BioNTech seek full US approval to vaccinate above 16sThe two pharma companies plan to submit data in support of the application over the coming weeks. FMTNews Pfizer BioNTech
US authorises Pfizer-BioNTech vaccine for 12-15 year oldsCovid-19 is generally milder in children but they can pass it on to older, more vulnerable adults. FMTNews